Nxstage Medical (NXTM) Reports In-Line Q4 EPS; Issues Light FY16 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
NxStage Reports Record Fourth Quarter and Full-Year 2015 Revenue
February 10, 2016 8:04 AM ESTLAWRENCE, Mass., Feb. 10, 2016 /PRNewswire/ -- Â
Highlights:
Full-Year Revenue Increases to $336 million, up 11% from 2014 Full-Year Home Revenue Increases to $183 million, up 16% from 2014 Full-Year Operating Income from Products Business Increases to $9 million Company Highlights Significant Product Introductions for the Next Three Years For Third Consecutive Year, Company Targets 15% Annual Home Revenue GrowthNxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today reported record revenue for the fourth quarter and fiscal year ended... More
